Funding for this research was provided by:
National Institute on Drug Abuse (P30DA027828, P30DA027828-10S1, R01DA037222; R01DA037222-05S1)
Accepted: 23 October 2020
First Online: 4 November 2020
Ethics approval and consent to participate
: Interviews were deemed exempt by Stanford University’s Institutional Review Board. Interviews took place following confidentiality and consent agreements approved by the IRB and recorded via a secure videoconference platform. The interviewee and named identities were blinded and de-identified for transcription and coding.
: All participants consented to having their anonymized responses appear in publication. Authors can provide copies of the consent and confidentiality form upon request.
: The authors declare that they have no competing interests.